JeffreyEdwardDunnMD

Neurology • Palo Alto, CA

Neuroimmunology/Multiple Sclerosis

Professor of Clinical Neurology

Join to view full profile

Dr. Dunn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dunn's full profile

Already have an account?

Office
213 Quarry Road
Palo Alto, CA 94304
Phone+1 650-736-4310

Fax+1 650-725-0390

Summary

Dr. Jeffrey Dunn is a neurologist in Palo Alto, CA and is affiliated with Stanford Health Care. He received his medical degree from Temple University School of Medicine and has been in practice 28 years. He specializes in neuroimmunology/multiple sclerosis and is experienced in neuroimmunology (multiple sclerosis).

Why I Went into Medicine with Dr. Jeffrey Dunn

Jeffrey Dunn, MD, world-recognized leader in the treatment of multiple sclerosis, discusses why his focus became multiple sclerosis (MS), a disease which cause

Jeffrey Dunn, MD

Jeffrey Dunn, MD is part of Stanford Profiles, official site for faculty, postdocs, students and staff information (Expertise, Bio, Research, Publications, and

Education & Training

University of WashingtonResidency, Neurology, 1990 - 1993
Lewis Katz School of Medicine at Temple UniversityClass of 1989
Haverford CollegeBA, French Literature, 1979 - 1983

Certifications & Licensure

CA State Medical License 2008 - 2025
WA State Medical License 1990 - 2008
American Board of Psychiatry and Neurology Neurology

Clinical Trials

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis Start of enrollment: 2024 Apr 10
Recruiting
Phase 1
Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) Start of enrollment: 2019 Dec 19
Recruiting
Phase 3

Publications & Presentations

PubMed

2 citations
Single-cell peripheral immunoprofiling of lewy body and Parkinson's disease in a multi-site cohort.
Thanaphong Phongpreecha, Kavita Mathi, Brenna Cholerton, Eddie J Fox, Natalia Sigal
Molecular Neurodegeneration. 2024-08-01
1 citations
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma.
Esther H Nie, Yi-Jiun Su, John H Baird, Neha Agarwal, Sushma Bharadwaj
Blood Advances. 2024-03-26
5 citations
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL.
Saurabh Gawde, Agnieshka Agasing, Neal Bhatt, Mackenzie Toliver, Gaurav Kumar
Multiple Sclerosis and Related Disorders. 2022-07-01

Authored Content

Clonally expanded B cells in Multiple Sclerosis bind EBV EBNA1 and GlialCAMJanuary 2022

Press Mentions

‘Military Police’ Cells Arise to Arrest Infection-Induced Autoimmunity, Study FindsMarch 8th, 2022
Annual Awards Honor Outstanding Teaching, Patient CareJune 22nd, 2017
Stanford Neuroscience Health Center Opens to Patients TodayJanuary 11th, 2016
Join now to see all